Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02263391 · ClinicalTrials.gov registry record · NA
HIV Risk and Prevention in Women
A NA study, sponsored by University of Oklahoma.
- Completed
- Registry status
- NA
- Development phase
- 200
- Enrollment target
NCT02263391 is a NA study that has completed, run by University of Oklahoma. The registered enrollment target is 200 participants.
The verdict
NCT02263391, a NA study, has completed, sponsored by University of Oklahoma.
- COMPLETED
- Registry status
- NA
- Development phase
- 200 participants
- Enrollment target
Study Summary
This study gathers information about HIV testing utilization and influences on HIV testing decisions among young, general population Russian women at-risk of HIV exposure. The study compares HIV testing acceptance across two types of low-barrier testing strategies (opt-in vs. opt-out) and conducts one of the first randomized experimental comparisons of these strategies. The overarching goal is to gain knowledge that can be used to increase utilization of HIV testing among at-risk young women and offer gender-specific strategies for improving prevention.
Interventions
- BEHAVIORAL Focus Group
- BEHAVIORAL Opt-in or Opt-out testing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2014-03 |
| Est. Completion | 2016-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02263391
The ClinicalTrials.gov registry entry for NCT02263391 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Oklahoma, which has 358 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Focus Group is the first listed.
NCT02263391 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02263391 about?
NCT02263391 is a clinical study titled "HIV Risk and Prevention in Women". This study gathers information about HIV testing utilization and influences on HIV testing decisions among young, general population Russian women at-risk of HIV exposure. The study compares HIV testing acceptance across two types of low-barrier testing strategies (opt-in vs. opt-out) and conducts o...
What is the current status of trial NCT02263391?
This trial is currently completed. It is a NA study. The enrollment target is 200 participants. The study started on 2014-03. Estimated completion is 2016-01.
What interventions are being tested in trial NCT02263391?
The interventions under investigation include: Focus Group (BEHAVIORAL), Opt-in or Opt-out testing (BEHAVIORAL).
Who is sponsoring clinical trial NCT02263391?
This trial is sponsored by University of Oklahoma, which has 358 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.